Estuardo Aguilar-Cordova
Founder bei CANDEL THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.03.2024
Profil
Estuardo Aguilar-Cordova is the founder and currently holds the position of Director at Candel Therapeutics, Inc., a company founded in 2002.
He previously worked as the Deputy Director-Harvard Gene Therapy Initiative at Harvard Medical School and as a Scientific Advisor at Nemucore Medical Innovations, Inc. Dr. Aguilar-Cordova obtained his undergraduate degree from California State University-Bakersfield and holds doctorate degrees from the University of California, Davis and Universidad Del Valle De Guatemala.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CANDEL THERAPEUTICS, INC.
10,91% | 01.04.2024 | 3 153 815 ( 10,91% ) | 5 Mio $ | 31.03.2024 |
Aktive Positionen von Estuardo Aguilar-Cordova
| Unternehmen | Position | Beginn |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Founder | 01.01.2002 |
Ehemalige bekannte Positionen von Estuardo Aguilar-Cordova
| Unternehmen | Position | Ende |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Director/Board Member | - |
Ausbildung von Estuardo Aguilar-Cordova
| California State University-Bakersfield | Undergraduate Degree |
| University of California, Davis | Doctorate Degree |
| Universidad Del Valle De Guatemala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CANDEL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Nemucore Medical Innovations, Inc. is a clinical development company. It specializes in the development and commercialization of molecularly targeted therapeutics for the treatment of multi-drug resistant cancers with an emphasis on women's oncology. The company was founded by Timothy P. Coleman, Yuri Lvov, Vladimir Torchilin and Mansoor Amiji in 2008 and is headquartered in Wellesley, MA. | Health Technology |
